SPY452.16-0.25 -0.06%
DIA354.78-1.25 -0.35%
IXIC15,182.58+60.90 0.40%

Oppenheimer Initiates Coverage On Humacyte with Outperform Rating, Announces Price Target of $16

Oppenheimer analyst Suraj Kalia initiates coverage on Humacyte (NASDAQ:HUMA) with a Outperform rating and announces Price Target of $16.

Benzinga · 09/24/2021 05:23
Oppenheimer analyst Suraj Kalia initiates coverage on Humacyte (NASDAQ:HUMA) with a Outperform rating and announces Price Target of $16.